Advani, Aman, and Saad Ahmed Mughal. “Luspatercept (REBLOZYL): A Game-Changer in Reducing Transfusion Burden for β-Thalassemia Patients”. Innovative Research in Applied, Biological and Chemical Sciences, vol. 3, no. 1, June 2025, https://doi.org/10.62497/irabcs.150.